|
Agilent in Life Sciences |
|
|
|
|
| |
Markets |
|
Agilent’s life sciences business addresses the needs of four key markets: gene expression, proteomics, informatics, and pharmaceutical analysis. |
|
 |
Gene expression research enables scientists to compare the gene activity of diseased versus healthy cells, providing insight into the genetic causes of disease. Agilent is second leading provider of gene expression solutions, with more than 500 customers worldwide. |
 |
Proteomics encompasses the large-scale study of proteins, including protein identification and characterization. Agilent provides complete liquid chromatography/mass spectrometry-based solutions for protein identification, from protein isolation through data analysis, as well as protein LabChips for protein quality assessment. |
 |
Informatics enables scientists to pull together disparate sets of biological data and analyze the information. Agilent offers a range of informatics solutions spanning applications in gene expression, genotyping and protein identification. The anticipated acquisition of Silicon Genetics positions Agilent as a market leader in this field. |
 |
Agilent is a market leader in pharmaceutical analysis , which focuses on the later stages of the pharmaceutical value chain including drug development, QA/QC and manufacturing. Agilent provides instrumentation, data systems and compliance services that are designed to meet the requirements of the regulated lab. |
